Rhenman & Partners Asset Management AB - MEDICINES CO ownership

MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 239 filers reported holding MEDICINES CO in Q2 2019. The put-call ratio across all filers is 1.08 and the average weighting 0.4%.

Quarter-by-quarter ownership
Rhenman & Partners Asset Management AB ownership history of MEDICINES CO
ValueSharesWeighting
Q3 2019$7,650,000
+4.9%
153,000
-23.5%
0.96%
+19.4%
Q2 2019$7,294,000
+100.7%
200,000
+53.8%
0.80%
+88.9%
Q1 2019$3,634,000
+40.6%
130,000
-3.7%
0.42%
+44.1%
Q4 2018$2,584,000
-36.0%
135,0000.0%0.30%
-27.2%
Q3 2018$4,038,000
+0.0%
135,000
+22.7%
0.40%
-1.9%
Q2 2018$4,037,000
+22.6%
110,000
+10.0%
0.41%
+1.7%
Q1 2018$3,294,000100,0000.41%
Other shareholders
MEDICINES CO shareholders Q2 2019
NameSharesValueWeighting ↓
Sarissa Capital Management LP 4,202,000$356,917,00029.62%
SYQUANT CAPITAL SAS 505,030$42,897,00022.09%
Moab Capital Partners 521,987$44,338,00017.51%
Antipodean Advisors LLC 321,000$27,266,00015.60%
RAMIUS ADVISORS LLC 419,826$35,660,00015.34%
DLD Asset Management, LP 3,275,900$278,255,00015.00%
Foresite Capital Management IV, LLC 403,217$34,249,00014.78%
WHITE SQUARE CAPITAL LLP 239,331$20,329,00014.70%
Davide Leone & Partners Investment Co Ltd. 1,146,192$97,358,00012.50%
Quad Capital Management Advisors LLC 8,640$734,00011.19%
View complete list of MEDICINES CO shareholders